Catalyst Wire Dossier Catalyst Wire Dossier

Tekturna HCT

aliskiren/hydrochlorothiazide · Novartis
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tekturna HCT, covering 2011-01-12 to 2011-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension [Phase 3]

See pricing